PUBLISHER: IMARC | PRODUCT CODE: 1541062
PUBLISHER: IMARC | PRODUCT CODE: 1541062
The global enteral feeding devices market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.
Enteral feeding devices refer to various tools and equipment used for the delivery of nutrients directly into the digestive tract through a feeding tube. This technique is primarily used for patients experiencing difficulties in the oral intake of food products, liquids and nutritional supplements. Some of the commonly used enteral feeding devices include feeding pumps, tubes, giving sets, enteral syringes and consumables. These devices enable consistent and accurate delivery of food containing proteins, carbohydrates, fats, water, minerals and vitamins. In comparison to the traditionally used polyvinylchloride feeding tubes, novel silicon-based variants are more flexible and do not cause irritation upon exposure to digestive enzymes.
The increasing prevalence of chronic diseases, such as diabetes, cancer and gastrointestinal ailments, is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population that is more susceptible to such medical illnesses is driving the market growth. Diseases and neurological conditions, such as multiple sclerosis, stroke and dementia, impact the patient's ability to swallow and cause malnourishment. This has enhanced the demand for enteral feeding devices that can aid in providing nutritional support through oral supplements and feeding tubes. In line with this, the advent of home enteral nutrition is also creating a positive outlook for the market. Additionally, various technological advancements, such as the development of low-profile gastrostomy buttons that are suitable for both children and adult patients, are contributing to the market growth. Other factors, including improving healthcare infrastructure, along with the growing demand for neonatal and preterm enteral feeding devices, are expected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteral feeding devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, age group, application and end user.
Enteral Feeding Pumps
Enteral Feeding Tubes
Giving Sets
Enteral Syringes
Consumables
Others
Adults
Pediatrics
Oncology
Gastroenterology
Neurology
Diabetes
Hypermetabolism
Others
Hospitals
Ambulatory Surgery Centers
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Amsino International Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), BD (Becton Dickinson and Company), Boston Scientific Corporation, Cardinal Health Inc., Conmed Corporation, Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA) and Moog Inc.